XCELLERATE
Swiss trademark · 616069 · Word mark · In force
Register entry
- Registration number
- 616069
- Application number
- 53815/2011
- Status
- In force
- Type
- Word mark
- Filed
- Mar 29, 2011
- Registered
- Jun 1, 2011
- Published
- Jun 1, 2011
- Protected until
- Mar 29, 2031
- Priority
- 30.09.2010 US
- Language of procedure
- French
- Source
- Swissreg
Goods and services
Science, technology and IT
Conduite d'essais cliniques de produits pharmaceutiques et de dispositifs médicaux; services de recherche scientifique, à savoir suivi, analyse, prévision et présentation de données dans le domaine des essais cliniques de produits pharmaceutiques et de dispositifs médicaux.
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Nov 1, 2023
Holder’s address changed
- Owner
- Labcorp Drug Development Inc., 206 Carnegie Center, Princeton, NJ 08540-6233, USA → Fortrea, Inc., 206 Carnegie Center, Princeton, NJ 08540-6233, USA
Published in Swissreg on 01.11.2023
- Jan 11, 2023
Agent removed
- Representative
- B.M.G. Avocats, 8c, avenue de Champel,, Case postale 385, 1211 Genève 12 (removed)
Published in Swissreg on 11.01.2023
- Jan 11, 2023
Agent entered
- Representative
- Meisser & Partners AG, Schulstrasse 1, 7302 Landquart
Published in Swissreg on 11.01.2023
- Jan 11, 2023
Holder’s address changed
- Owner
- Covance Inc., 210 Carnegie Center, Princeton, NJ 08540-6233, USA → Labcorp Drug Development Inc., 206 Carnegie Center, Princeton, NJ 08540-6233, USA
Published in Swissreg on 11.01.2023
- Mar 26, 2021
Renewed
Published in Swissreg on 26.03.2021
- Jun 1, 2011
Registered
Published in Swissreg on 01.06.2011
Parties
The register names each party by name and address. A party is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.